Ziconotide
Brain & neurobiology
It was developed as a non opioid analgesic with clinical trials in severe chronic pain.
An authorisation applies to at least one defined finished product in a stated jurisdiction; it does not apply automatically to this catalogue material.
What is Ziconotide?
Ziconotide is a synthetic conopeptide derived from cone snail venom that blocks N type calcium channels and is used in neuroscience and pain research; the catalogue item denotes the research grade peptide.
Which research context has Ziconotide been associated with?
Ziconotide is associated with neuroscience research as a conopeptide N type calcium channel blocker, developed and investigated in clinical trials for severe chronic pain and studied in preclinical models of nociception and neuronal calcium channel pharmacology.
What documentation is available for Ziconotide?
Ziconotide: Batch documents are not yet linked on this site. For this conopeptide N type calcium channel blocker required evidence includes batch identifier and release date; identity by liquid chromatography mass spectrometry/intact mass and disulfide/connectivity confirmation as appropriate; analytical HPLC/UPLC chromatogram with method and purity specification; peptide content, counterion and residual solvent/water details; and potency/assay documentation. No batch documentation is shown as available until the record for that specific item is linked and reviewed.
What determines the storage conditions for Ziconotide?
Ziconotide: Storage depends on the documented supplied presentation; as a conopeptide often containing multiple disulfides confirm dry/lyophilised versus solution form, solvent or buffer composition, counterion and concentration, pH sensitivity, container closure compatibility and strict assessment of disulfide/conformational integrity and oxidation liability. No storage instruction is shown as available until the stability record for that specific item is linked and reviewed.